High Prevalence of Chromosomal blaCTX-M-14 in Escherichia coli Isolates Possessing blaCTX-M-14

Antimicrob Agents Chemother. 2016 Mar 25;60(4):2582-4. doi: 10.1128/AAC.00108-16. Print 2016 Apr.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Chromosome Mapping
  • Chromosomes, Bacterial / chemistry*
  • Escherichia coli / drug effects
  • Escherichia coli / enzymology
  • Escherichia coli / genetics*
  • Escherichia coli / growth & development
  • Escherichia coli Infections / diet therapy
  • Escherichia coli Infections / microbiology
  • Gene Dosage
  • Gene Expression
  • Homes for the Aged*
  • Humans
  • Japan
  • Mutagenesis, Insertional
  • Nursing Homes*
  • Plasmids / chemistry
  • Plasmids / metabolism
  • Sequence Analysis, DNA
  • beta-Lactam Resistance / genetics*
  • beta-Lactamases / genetics*
  • beta-Lactamases / metabolism
  • beta-Lactams / pharmacology

Substances

  • Anti-Bacterial Agents
  • beta-Lactams
  • beta-lactamase CTX-M-14
  • beta-Lactamases

Grants and funding

This study is also supported by the Japan Agency for Medical Research and Development/Japan International Cooperation Agency, Science and Technology Research Partnership for Sustainable Development (AMED/JICA, SATREPS).